Evidence map›Paper›PMID 28855627›Full record

ArticleScientific reports2017

Induced Pluripotent Stem Cell-Derived Neural Stem Cell Therapy Enhances Recovery in an Ischemic Stroke Pig Model.

Emily W Baker, Simon R Platt, Vivian W Lau, Harrison E Grace, Shannon P Holmes, Liya Wang, Kylee Jo Duberstein, Elizabeth W Howerth, Holly A Kinder, Steve L Stice and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. The enigma of vascular dementia: current state and emerging perspectives.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  3. Review
  4. Article
  5. Innovative approaches for the treatment of stroke: a recent update.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Emily W BakerRegenerative Bioscience Center, University of Georgia, Athens, GA, 30602, USA.
Simon R PlattRegenerative Bioscience Center, University of Georgia, Athens, GA, 30602, USA.
Vivian W LauRegenerative Bioscience Center, University of Georgia, Athens, GA, 30602, USA.
Harrison E GraceRegenerative Bioscience Center, University of Georgia, Athens, GA, 30602, USA.
Shannon P HolmesRegenerative Bioscience Center, University of Georgia, Athens, GA, 30602, USA.
Liya WangDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, 30329, USA.
Kylee Jo DubersteinRegenerative Bioscience Center, University of Georgia, Athens, GA, 30602, USA.
Elizabeth W HowerthRegenerative Bioscience Center, University of Georgia, Athens, GA, 30602, USA.
Holly A KinderRegenerative Bioscience Center, University of Georgia, Athens, GA, 30602, USA.
Steve L SticeRegenerative Bioscience Center, University of Georgia, Athens, GA, 30602, USA.
David C HessDepartment of Neurology, Augusta University, Augusta, GA, 30912, USA.
Hui MaoDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, 30329, USA.
Franklin D WestRegenerative Bioscience Center, University of Georgia, Athens, GA, 30602, USA. westf@uga.edu.
University of Georgia · USEmory University · USAugusta University · US

Funding

Combined Nanoparticle and Neural Stem Cell Therapies in a Pig Model of StrokeR01NS093314 · NINDS · UNIVERSITY OF GEORGIA · PI WEST, FRANKLIN D · 2015 to 2019
$2.4M
NINDS NIH HHS R01 NS093314
6 · The paper itself

Abstract

Induced pluripotent stem cell-derived neural stem cells (iNSCs) have significant potential as an autologous, multifunctional cell therapy for stroke, which is the primary cause of long term disability in the United States and the second leading cause of death worldwide. Here we show that iNSC transplantation improves recovery through neuroprotective, regenerative, and cell replacement mechanisms in a novel ischemic pig stroke model. Longitudinal multiparametric magnetic resonance imaging (MRI) following iNSC therapy demonstrated reduced changes in white matter integrity, cerebral blood perfusion, and brain metabolism in the infarcted tissue. The observed tissue level recovery strongly correlated with decreased immune response, enhanced neuronal protection, and increased neurogenesis. iNSCs differentiated into neurons and oligodendrocytes with indication of long term integration. The robust recovery response to iNSC therapy in a translational pig stroke model with increased predictive potential strongly supports that iNSCs may be the critically needed therapeutic for human stroke patients.

Indexed as

AnimalsBiomarkersCell DifferentiationCerebral CortexDisease Models, AnimalGene ExpressionHumansInduced Pluripotent Stem CellsInfarction, Middle Cerebral ArteryMagnetic Resonance ImagingMaleNerve Tissue ProteinsNeurogenesisNeuronsOligodendrogliaStem Cell TransplantationBiomarkersNerve Tissue Proteins

Identifiers

PMID28855627
PMCPMC5577218
OpenAlexW2749074606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.